Heavy drinking and use of sedative or anxiolytic drugs among aging men: an 11-year follow-up of the FinDrink study

Ann Pharmacother. 2011 Oct;45(10):1240-7. doi: 10.1345/aph.1Q375. Epub 2011 Sep 6.

Abstract

Background: Most studies on heavy drinking and sedative/anxiolytic drug use have been cross-sectional, and evidence for a possible temporal association is lacking.

Objective: To prospectively investigate whether heavy drinking predicts initiation, continuation, or discontinuation of sedative/anxiolytic drugs at 4 and 11 years and, conversely, whether sedative/anxiolytic drug use predicts heavy drinking.

Method: This was a longitudinal population-based study conducted in Kuopio, Finland. An age-stratified random sample of 1516 men aged 42, 48, 54, and 60 years received a structured clinical examination at baseline (August 1986-December 1989). Follow-up clinical examinations were conducted at 4 (n = 1038) and 11 (n = 854) years. Multinomial logistic regression was used to compute odds ratios and 95% confidence intervals for the association between sedative/anxiolytic drug use and initiation, continuation, and discontinuation of heavy drinking (≥ 14 drinks/wk). The reverse association between heavy drinking and sedative/anxiolytic drug use was also investigated. Regression models were adjusted for age, working status, smoking, and depressive symptoms.

Results: At baseline 12.9% (134/1038) of participants were heavy drinkers and 4.0% (41/1030) used sedative/anxiolytic drugs. In multivariate analyses, baseline heavy drinking predicted initiation of sedative/anxiolytic drug use at 4 years (OR 2.96; 95% CI 1.23 to 7.15). Conversely, baseline sedative/anxiolytic drug use predicted continuation of heavy drinking at 11 years in unadjusted analysis (OR 3.30; 95% CI 1.19 to 8.44). However, the association was not statistically significant in adjusted analyses (OR 2.69; 95% CI 0.86 to 8.44).

Conclusions: The main finding of this study was the association between heavy drinking and subsequent initiation of sedative/anxiolytic drugs that was not fully explained by baseline depressive symptoms. This may inform strategies to optimize the use of sedative/anxiolytic drugs, and assist in the early identification of patients at risk of heavy drinking. Clinicians should consider a patient's alcohol consumption prior to prescribing or dispensing sedative/anxiolytic drugs. Clinicians should also monitor patients prescribed sedative/anxiolytic drugs for subsequent heavy drinking.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alcohol Drinking / epidemiology
  • Alcohol Drinking / psychology
  • Alcoholic Intoxication / complications
  • Alcoholic Intoxication / epidemiology
  • Alcoholic Intoxication / psychology
  • Alcoholism / complications
  • Alcoholism / epidemiology*
  • Alcoholism / psychology
  • Anti-Anxiety Agents / administration & dosage*
  • Cohort Studies
  • Finland / epidemiology
  • Humans
  • Hypnotics and Sedatives / administration & dosage*
  • Illicit Drugs
  • Logistic Models
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Prospective Studies
  • Psychotropic Drugs / administration & dosage
  • Regression Analysis
  • Risk
  • Substance-Related Disorders / complications
  • Substance-Related Disorders / epidemiology*
  • Substance-Related Disorders / psychology
  • Surveys and Questionnaires

Substances

  • Anti-Anxiety Agents
  • Hypnotics and Sedatives
  • Illicit Drugs
  • Psychotropic Drugs